IL89691A - Pharmaceutical preparations containing the history of bites] 3, 4 - Dihydro - H2 - 1 - Benzofiran [for lowering blood pressure, certain such new compounds and their preparation - Google Patents

Pharmaceutical preparations containing the history of bites] 3, 4 - Dihydro - H2 - 1 - Benzofiran [for lowering blood pressure, certain such new compounds and their preparation

Info

Publication number
IL89691A
IL89691A IL8969189A IL8969189A IL89691A IL 89691 A IL89691 A IL 89691A IL 8969189 A IL8969189 A IL 8969189A IL 8969189 A IL8969189 A IL 8969189A IL 89691 A IL89691 A IL 89691A
Authority
IL
Israel
Prior art keywords
blood pressure
formula
compound
pressure reducing
parts
Prior art date
Application number
IL8969189A
Other languages
English (en)
Hebrew (he)
Other versions
IL89691A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL89691(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL89691A0 publication Critical patent/IL89691A0/xx
Publication of IL89691A publication Critical patent/IL89691A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
IL8969189A 1988-03-23 1989-03-21 Pharmaceutical preparations containing the history of bites] 3, 4 - Dihydro - H2 - 1 - Benzofiran [for lowering blood pressure, certain such new compounds and their preparation IL89691A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17274788A 1988-03-23 1988-03-23

Publications (2)

Publication Number Publication Date
IL89691A0 IL89691A0 (en) 1989-09-28
IL89691A true IL89691A (en) 1994-04-12

Family

ID=22629045

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8969189A IL89691A (en) 1988-03-23 1989-03-21 Pharmaceutical preparations containing the history of bites] 3, 4 - Dihydro - H2 - 1 - Benzofiran [for lowering blood pressure, certain such new compounds and their preparation

Country Status (19)

Country Link
EP (1) EP0334429B1 (US06534493-20030318-C00166.png)
JP (1) JPH0637487B2 (US06534493-20030318-C00166.png)
KR (1) KR970011287B1 (US06534493-20030318-C00166.png)
AU (1) AU621591B2 (US06534493-20030318-C00166.png)
CA (1) CA1337432C (US06534493-20030318-C00166.png)
CY (1) CY1802A (US06534493-20030318-C00166.png)
DE (2) DE19675037I1 (US06534493-20030318-C00166.png)
DK (1) DK174422B1 (US06534493-20030318-C00166.png)
ES (1) ES2052881T3 (US06534493-20030318-C00166.png)
GR (1) GR3006972T3 (US06534493-20030318-C00166.png)
HK (1) HK123594A (US06534493-20030318-C00166.png)
HU (1) HU211539A9 (US06534493-20030318-C00166.png)
IE (1) IE62159B1 (US06534493-20030318-C00166.png)
IL (1) IL89691A (US06534493-20030318-C00166.png)
LU (1) LU88842I2 (US06534493-20030318-C00166.png)
NL (1) NL950031I2 (US06534493-20030318-C00166.png)
NZ (1) NZ228321A (US06534493-20030318-C00166.png)
PT (1) PT90095B (US06534493-20030318-C00166.png)
ZA (1) ZA892179B (US06534493-20030318-C00166.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
CA2207333C (en) * 1994-12-28 2006-10-17 Janssen Pharmaceutica, Naamloze Vennootschap Use of nebivolol as an anti-atherogenic
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5670667A (en) * 1995-07-25 1997-09-23 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
PT1121111E (pt) 1998-10-15 2010-05-17 Imp Innovations Ltd Compostos para o tratamento de perda de peso
WO2002087508A2 (en) 2001-05-02 2002-11-07 Nitromed, Inc. Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
ATE512961T1 (de) * 2004-07-30 2011-07-15 Torrent Pharmaceuticals Ltd Amorphes nebivolol hydrochlorid und seine herstellung
EP1776354B1 (en) * 2004-08-11 2010-04-21 Hetero Drugs Limited A novel process for preparation of nebivolol intermediates
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
WO2006083780A2 (en) * 2005-01-31 2006-08-10 Mylan Laboratories, Inc. Glucuronidated nebivolol
SG175477A1 (en) 2005-01-31 2011-11-28 Mylan Lab Inc Hydroxylated nebivolol metabolites
CN100546987C (zh) * 2005-03-03 2009-10-07 浙江医药股份有限公司新昌制药厂 Dl-奈必洛尔及其盐酸盐的制备方法
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1973895A1 (en) 2006-01-18 2008-10-01 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
CA2667919C (en) * 2006-11-27 2014-10-28 Zach System S.P.A. Process for preparing nebivolol
PT2102196E (pt) * 2006-11-27 2012-10-31 Zach System Spa Processo para a preparação de nebivolol
GB0624282D0 (en) 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
WO2008089549A1 (en) 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
CN101531651B (zh) * 2008-03-13 2011-05-04 四川大学 光学活性3,4-二氢-2h-1-苯并吡喃-2-羧酸和3,4-二氢-4-氧-2h-1-苯并吡喃-2-羧酸类化合物的制备方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) * 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
US8785664B2 (en) 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
IT1402974B1 (it) * 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
WO2014111903A2 (en) 2013-01-21 2014-07-24 Cadila Pharmaceuticals Limited A process for the preparation of 6-fluoro-3,4-dihydro-2h-chromene- 2-carbaldehyde
PT2907809T (pt) 2014-02-14 2019-01-16 Corden Pharma Int Gmbh Processo sem base para a preparação de intermediários de cetona utilizáveis para fabrico de nebivolol
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
CN107531662B (zh) 2015-05-19 2021-08-06 浙江奥翔药业股份有限公司 奈必洛尔的合成方法及其中间体化合物
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol

Also Published As

Publication number Publication date
DK146289A (da) 1989-09-24
DK174422B1 (da) 2003-02-24
KR890014510A (ko) 1989-10-24
AU621591B2 (en) 1992-03-19
IE890906L (en) 1989-09-23
ZA892179B (en) 1990-11-28
PT90095B (pt) 1994-11-30
CY1802A (en) 1995-02-17
GR3006972T3 (US06534493-20030318-C00166.png) 1993-06-30
PT90095A (pt) 1989-11-10
AU3074289A (en) 1989-09-28
JPH0637487B2 (ja) 1994-05-18
IE62159B1 (en) 1994-12-28
HK123594A (en) 1994-11-18
ES2052881T3 (es) 1994-07-16
IL89691A0 (en) 1989-09-28
EP0334429B1 (en) 1992-11-19
LU88842I2 (fr) 1997-01-27
DK146289D0 (da) 1989-03-22
CA1337432C (en) 1995-10-24
NZ228321A (en) 1991-02-26
DE68903516D1 (de) 1992-12-24
NL950031I1 (US06534493-20030318-C00166.png) 1996-02-01
NL950031I2 (nl) 1997-01-06
DE68903516T2 (de) 1993-04-01
EP0334429A1 (en) 1989-09-27
JPH01283220A (ja) 1989-11-14
HU211539A9 (en) 1995-12-28
DE68903516C5 (de) 2017-07-13
DE19675037I1 (de) 2003-09-04
KR970011287B1 (ko) 1997-07-09

Similar Documents

Publication Publication Date Title
CA1337432C (en) Method of lowering the blood pressure
US6545040B1 (en) Method of lowering the blood pressure
JP3220266B2 (ja) アザヘテロサイクリルメチル−クロマン
US11434205B2 (en) Substituted imidazole carboxylate derivatives and the use thereof
IL85290A (en) 3, 4-Dihydro-H-converted benzopyrans, processes for their preparation and pharmaceutical preparations containing them
CN110003188B (zh) 取代吡咯甲酸酯类衍生物及其用途
CA2907964A1 (en) Phenyl derivative
CZ280543B6 (cs) Způsob výroby nových thienopyranových derivátů
JPH02184686A (ja) 新規ベンゾピラニルピロリノン誘導体
WO1998014444A1 (fr) Derives de n-(benzothiazol-2-yl)piperidine-1-ethanamine, leur preparation et leur application en therapeutique
JP2024522633A (ja) ベンゾオキサジノン誘導体
US4987133A (en) Salicylic acid derivatives
CN109071392A (zh) 苯环衍生物及其制备方法和在医药上的应用
WO2007001119A1 (en) 2,2-dimethyl-3-alkylether-4-alkoxy-6-alkyl amino benzopyrane and the derivatives thereof, and pge2 production inhibitors containing the same as an effective ingredient
CN111356677A (zh) 四氢异喹啉类衍生物及其制备方法和用途
CN103450164B (zh) 格尔德霉素衍生物及其制备方法和用途
JPH0138089B2 (US06534493-20030318-C00166.png)
JP2023549962A (ja) Ｐｕ．１阻害剤としての化合物
AU769948B2 (en) Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them
JP3054207B2 (ja) シクロプロパクロメン誘導体
JPH11506094A (ja) ３（２ｈ）−ピリダジノン誘導体及びその化合物含有の製薬学的組成物
JPS6148829B2 (US06534493-20030318-C00166.png)
KR880000043B1 (ko) Ｎ－아릴－피레라진알칸아미드의 제조법
EP0404115A1 (en) Bis(benzylpyrrolidine)Derivatives as dopamine agonists
Morzycki et al. Three new derivatives of 3-amino-1, 2-propanediol, their spectral properties and biological evaluation

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed